Given that HMGCS2 shows a downregulation trend in many cancer types, it is important to further investigate the consequences of HMGCS2 downregulation in renal clear cell carcinoma and normal human kidney cells. The gene discussed is HMGCS2; the disease is clear cell renal carcinoma.